<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Lung Composite Allocation Score (CAS) for candidates age 12 and older</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Lung Composite Allocation Score (CAS) for candidates age 12 and older</h1>
<div class="graphic"><div class="figure"><div class="ttl">Lung Composite Allocation Score (CAS) for candidates age 12 and older</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup> <colgroup width="80%"></colgroup> <tbody> <tr> <td class="subtitle1_left_white">Step 1: Waiting list urgency</td> <td>The transplant center enters the factors in part 1 below on the UNet website. A Cox proportional hazards model has been used to derive an estimate of the expected number of days a candidate would live without a transplant during an additional year on the waitlist. The patient receives up to <strong>25 points</strong> in a non-linear manner (Number of points = [25^(1-expected_survival/365) – 1]/24).</td> </tr> <tr> <td class="subtitle1_left_white">Step 2: Expected post-transplant survival</td> <td>The transplant center enters the factors in part 2 below on the UNet website. A Cox proportional hazards model has been used to derive an estimate of the number of days a recipient would be expected to live during the first five year post-transplant. The patient receives up to <strong>25 points</strong> linearly based on this is the post-transplant survival measure (Number of points = 25 * estimated_survival/1826).</td> </tr> <tr> <td class="subtitle1_left_white">Step 3: Biologic compatibility</td> <td>The patient's biologic compatibility is determined non-linearly based on 1) Calculated Panel Reactive Antibodies (CPRA), 2) blood type, and 3) height (<strong>5 points each, 15 total points</strong>)</td> </tr> <tr> <td class="subtitle1_left_white">Step 4: Patient access</td> <td>Additional points are given to certain groups of patients to increase their access to lung transplantation. Pediatric patients receive <strong>20 points</strong> and prior living organ donors reveive <strong>5 points.</strong></td> </tr> <tr> <td class="subtitle1_left_white">Step 5: Placement efficiency</td> <td>The final <strong>10 points</strong> are allocated based on distance between the donor hospital and transplant centerto account for travel costs, coordination costs, risk of travel to personnel and organs, as well as potentially detrimental effects of organ ischemia associated with transporting lungs long distances.</td> </tr> <tr> <td class="subtitle1_left" colspan="2">Part 1 – Waiting list urgency measure:</td> </tr> <tr> <td colspan="2"> <ol> <li>Age</li> <li>Serum bilirubin</li> <li>Body mass index (BMI)</li> <li>Continuous mechanical ventilation</li> <li>Serum creatinine</li> <li>Diagnosis*</li> <li>Functional status<sup>¶</sup></li> <li>Supplemental O<sub>2</sub> required at rest</li> <li>pCO<sub>2</sub><sup>Δ</sup></li> <li>Pulmonary artery systolic pressure</li> <li>6-minute walk distance</li> </ol> </td> </tr> <tr> <td class="subtitle1_left" colspan="2">Part 2 – Post-transplant survival measure:</td> </tr> <tr> <td colspan="2"> <ol> <li>Age</li> <li>Serum creatinine</li> <li>Cardiac index at rest</li> <li>Continuous mechanical ventilation</li> <li>Diagnosis*</li> <li>Functional status<sup>¶</sup></li> <li>6-minute walk distance</li> </ol> </td> </tr> </tbody></table></div><div class="graphic_footnotes">* Diagnosis groups:
<ul class="none">
<li><strong>Group A:</strong> Chronic obstructive pulmonary disease (COPD), alpha-1-antitrypsin, emphysema, lymphangioleiomyomatosis, bronchiectasis, sarcoidosis with a mean pulmonary artery pressure (MPAP) ≤30 mmHg.</li>
<li><strong>Group B:</strong> Pulmonary hypertension (idiopathic pulmonary arterial hypertension [IPAH], Eisenmenger syndrome, etc).</li>
<li><strong>Group C:</strong> Cystic fibrosis, immunodeficiency disorders (eg, hypogammaglobulinemia).</li>
<li><strong>Group D:</strong> Idiopathic pulmonary fibrosis (IPF), other causes of pulmonary fibrosis, other idiopathic interstitial pneumonias, connective tissue disease-associated interstitial lung disease, hypersensitivity pneumonitis, sarcoidosis with MPAP &gt;30 mmHg, bronchiolitis, lung retransplant, and other rare disorders.</li>
</ul>
<p class="extra_spacing">The post-transplant survival measure also separately factors in the following specific diagnoses: bronchiectasis, obliterative bronchiolitis, constrictive bronchiolitis, sarcoidosis ± MPAP &gt;30.</p>
<p>The waiting list urgency measure also separately factors in the following specific diagnoses: bronchiectasis, other causes of pulmonary fibrosis (including COVID-19), and sarcoidosis ± MPAP &gt;30.</p>
<p>¶ Functional status is a binary assessment of whether the patient requires assistance with activities of daily living.</p>
Δ pCO<sub>2</sub> may be taken from arterial, capillary or venous measurement. If venous, 6 mmHg will be subtracted to produce an equivalent arterial value. There is also an adjustment for an increase of greater than 15% over less than 6 months.</div><div class="graphic_reference">Adapted from: Organ Procurement and Transplantation Network (OPTN) Policies. Available at: <a href="https://optn.transplant.hrsa.gov/media/eavh5bf3/optn_policies.pdf" target="_blank">https://optn.transplant.hrsa.gov/media/eavh5bf3/optn_policies.pdf</a> (Accessed May 07, 2023). More information about the LAS calculator can be found at: <a href="https://optn.transplant.hrsa.gov/data/allocation-calculators/las-calculator/" target="_blank">https://optn.transplant.hrsa.gov/data/allocation-calculators/lung-cas-calculator/</a> (Accessed May 07, 2023).</div><div id="graphicVersion">Graphic 59818 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
